TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Bristol-Myers Squibb Norway AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
17,870
|
14,961
|
50,840 |
Financial expenses |
33
|
47
|
129 |
Earnings before taxes |
880
|
758
|
2,375 |
Total assets |
23,847
|
23,911
|
28,197 |
Current assets |
23,816
|
23,897
|
28,178 |
Current liabilities |
5,283
|
4,912
|
8,833 |
Equity capital |
18,564
|
19,000
|
19,364 |
- share capital |
89
|
76
|
80 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
77.8%
|
79.5%
|
68.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
4.9%
|
5.1%
|
4.7% |
Return on assets (ROA) |
3.8%
|
3.4%
|
8.9% |
Current ratio |
450.8%
|
486.5%
|
319.0% |
Return on equity (ROE) |
4.7%
|
4.0%
|
12.3% |
Change turnover |
3,860
|
-33,209
|
2,398 |
Change turnover % |
28%
|
-69%
|
5% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.